Novel approaches to the prevention and therapy of neonatal bacterial sepsis.
A variety of adjunctive treatments have been shown to offer potential benefits for neonates with sepsis. Most are not available clinically and those that are available still should be considered experimental or limited in their use; however, these efforts are far from complete and should continue to evolve in the coming years. Efforts toward the rapid diagnosis of bacterial infections are a necessary component in the eventual implementation of these potential novel strategies. As a better understanding of the intricate mechanisms of neonatal sepsis is developed, it will be possible to provide patients with an increasingly effective array of treatment and prevention strategies.
Perez
E M
EM
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Weisman
L E
LE
D001424:Bacterial Infections / Q000628:therapy*; D005078:Exchange Transfusion, Whole Blood; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007231:Infant, Newborn; D017708:Leukocyte Transfusion; D018805:Sepsis / Q000628:therapy*
D016756:Immunoglobulins, Intravenous; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor